
    
      The purpose of this study is to obtain and assay human aqueous samples following
      pre-operative dosing with 0.1% Brimonidine Purite™ (pH 7.8) or with 0.15% Brimonidine Purite®
      (pH 7.2) from patients undergoing routine cataract surgery in order to evaluate the aqueous
      concentration of the two formulations.
    
  